Back

Diagnostic and prognostic role of genotyping in HCM.

20 June 2017 (08:30 - 08:52)
Organised by:
Congress Presentation Part of: Hypertrophic cardiomyopathy genetics and clinical management Molecular biology / genetics EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Philippe Charron

Pitie Salpetriere APHP University Hospital, Paris (France)

3 More presentations in this session

Presentation thumbnail
Risk stratification of HCM in 2017: the European approach.
Professor P. Elliott (London, GB)
Slides Video
Presentation thumbnail
Atrial fibrillation and outcome in HCM: the American vs. European approach to risk stratification
Professor E. Arbustini (Pavia, IT)
Presentation thumbnail
Ablation in HCM.
Professor L. Di Biase (The Bronx, US)
Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy genetics and clinical management

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Phenotypic predictors of pathogenic variants in probands with hypertrophic cardiomyopathy
28 August 2022
thumbnail
Congress Session
Clinical course of specific cardiomyopathies
18 May 2025
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025
thumbnail
Congress Presentation
Genotype predicts heart failure independent of left ventricular ejection fraction and NT-proBNP levels in hypertrophic cardiomyopathy
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources